Conference
TIME TO FUNCTIONAL AND COGNITIVE DECLINE IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Authors
Nicholas GA; Hirte H; Easaw J; Muanza T; Roberge D; Mathieu D; Pitz M
Volume
19
Pagination
pp. 138-138
Publisher
OXFORD UNIV PRESS INC
Publication Date
November 1, 2017
Name of conference
Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS
Conference place
CA, San Francisco
Conference start date
November 15, 2017
Conference end date
November 19, 2017
Conference proceedings
NEURO-ONCOLOGY
ISSN
1522-8517